Infinity Pharmaceuticals, Inc. Total Liabilities
Infinity Pharmaceuticals, Inc. had Total Liabilities of $58.64 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-08-10
- 2023-06-30: Liabilities $58.64M.
- 2023-03-31: Liabilities $58.27M.
- 2022-12-31: Liabilities $61.20M.
- 2022-09-30: Liabilities $62.47M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2023-06-30 | $58.64M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $58.27M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $61.20M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $62.47M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $62.96M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $62.60M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $63.21M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $62.47M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $61.06M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $60.35M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $62.31M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $61.09M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $60.04M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $59.34M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $41.29M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $40.49M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $38.87M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $35.34M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $7.76M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $6.14M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $5.71M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.57M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $11.62M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $10.90M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $31.94M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $29.82M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $43.20M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $49.78M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $68.46M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $178.85M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $190.26M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $199.62M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $153.62M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $146.56M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $159.67M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $151.31M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $27.10M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $26.73M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $29.43M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $30.55M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $27.82M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $24.13M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $25.45M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $18.46M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $116.44M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $107.96M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $109.06M 10-K · filed 2013-03-05 | $109.06M 10-K · filed 2012-03-13 |
| 2011-09-30 | $69.63M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $66.42M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $75.08M 10-K · filed 2012-03-13 |